- Home
- CSGS vs NVCR Comparison
CSGS vs NVCR Comparison
Compare CSGS & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSGS
- NVCR
- Stock Information
- Founded
- CSGS 1994
- NVCR 2000
- Country
- CSGS United States
- NVCR Switzerland
- Employees
- CSGS N/A
- NVCR N/A
- Industry
- CSGS EDP Services
- NVCR Medical/Dental Instruments
- Sector
- CSGS Technology
- NVCR Health Care
- Exchange
- CSGS Nasdaq
- NVCR Nasdaq
- Market Cap
- CSGS 1.9B
- NVCR 1.9B
- IPO Year
- CSGS 1996
- NVCR 2015
- Fundamental
- Price
- CSGS $61.85
- NVCR $17.60
- Analyst Decision
- CSGS Buy
- NVCR Buy
- Analyst Count
- CSGS 8
- NVCR 7
- Target Price
- CSGS $68.29
- NVCR $32.43
- AVG Volume (30 Days)
- CSGS 191.2K
- NVCR 1.4M
- Earning Date
- CSGS 08-06-2025
- NVCR 07-24-2025
- Dividend Yield
- CSGS 2.04%
- NVCR N/A
- EPS Growth
- CSGS 33.32
- NVCR N/A
- EPS
- CSGS 2.92
- NVCR N/A
- Revenue
- CSGS $1,201,566,000.00
- NVCR $621,711,000.00
- Revenue This Year
- CSGS $4.49
- NVCR $5.56
- Revenue Next Year
- CSGS $3.92
- NVCR $9.19
- P/E Ratio
- CSGS $21.51
- NVCR N/A
- Revenue Growth
- CSGS 3.08
- NVCR 18.27
- 52 Week Low
- CSGS $40.89
- NVCR $14.17
- 52 Week High
- CSGS $67.60
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- CSGS 37.76
- NVCR 49.74
- Support Level
- CSGS $63.71
- NVCR $16.81
- Resistance Level
- CSGS $66.99
- NVCR $18.59
- Average True Range (ATR)
- CSGS 1.43
- NVCR 0.74
- MACD
- CSGS -0.25
- NVCR 0.08
- Stochastic Oscillator
- CSGS 3.02
- NVCR 56.18
About CSGS CSG Systems International Inc.
CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, the company generates revenue from the United States.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.